DOK5 Antibody Cat

Total Page：16

File Type：pdf, Size：1020Kb

DOK5 Antibody Cat. No.: 45-491 DOK5 Antibody 45-491 (1ug/ml) staining of paraffin embedded Human Tonsil. Microwaved antigen retrieval with citrate buffer pH6, HRP-staining. Specifications HOST SPECIES: Goat SPECIES REACTIVITY: Human HOMOLOGY: Expected Species Reactivity based on sequence homology: Mouse, Rat, Dog, Pig, Cow IMMUNOGEN: The immunogen for this antibody is: CLHRTETFPAYRSEH TESTED APPLICATIONS: ELISA, IHC, WB Peptide ELISA: antibody detection limit dilution 1:16000.Western Blot:In transfected HEK293 transiently expressing DOK5 a band of approx. 38kDa is observed. This band is not observed in the non-transfected HEK293. The calculated molecular size is 35.5kDa APPLICATIONS: according to NP_060901.2. Recommended concentration, 1-3ug/ml.Immunohistochemistry:In paraffin embedded tonsil, stains scattered cells in the interfollicular area compatible with mast cells. Recommended concentration, 1-2ug/ml. September 27, 2021 1 https://www.prosci-inc.com/dok5-antibody-45-491.html SPECIFICITY: #To_Delete#. POSITIVE CONTROL: 1) Cat. No. 1305 - Human Kidney Tissue Lysate 2) Cat. No. 1315 - Human Tonsil Tissue Lysate Properties Purified from goat serum by ammonium sulphate precipitation followed by antigen PURIFICATION: affinity chromatography using the immunizing peptide. CLONALITY: Polyclonal CONJUGATE: Unconjugated PHYSICAL STATE: Liquid Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum BUFFER: albumin. Aliquot and store at -20°C. Minimize freezing and thawing. CONCENTRATION: 500 ug/mL STORAGE CONDITIONS: Aliquot and store at -20˚C. Minimize freezing and thawing. Additional Info OFFICIAL SYMBOL: DOK5 DOK5, MGC16926, C20orf180, docking protein 5, downstream of tyrosine kinase 5, ALTERNATE NAMES: chromosome 20 open reading frame 180 ACCESSION NO.: NP_060901.2 PROTEIN GI NO.: 29544726 GENE ID: 55816 Background and References 1) Cai D, Dhe-Paganon S, Melendez PA, Lee J, Shoelson SE. Two new substrates in insulin REFERENCES: signaling, IRS5/DOK4 and IRS6/DOK5. J Biol Chem. 2003 Jul 11;278(28):25323-30. Epub 2003 May 01. ANTIBODIES FOR RESEARCH USE ONLY. For additional information, visit ProSci's Terms & Conditions Page. September 27, 2021 2 https://www.prosci-inc.com/dok5-antibody-45-491.html.

Copy Link

Recommended publications

Targeting PH Domain Proteins for Cancer Therapy
The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 12-2018 Targeting PH domain proteins for cancer therapy Zhi Tan Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Bioinformatics Commons, Medicinal Chemistry and Pharmaceutics Commons, Neoplasms Commons, and the Pharmacology Commons Recommended Citation Tan, Zhi, "Targeting PH domain proteins for cancer therapy" (2018). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 910. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/910 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. TARGETING PH DOMAIN PROTEINS FOR CANCER THERAPY by Zhi Tan Approval page APPROVED: _____________________________________________ Advisory Professor, Shuxing Zhang, Ph.D. _____________________________________________
[Show full text]
The Roma Paradigm
The Counteracting Effects of Demography on Functional Genomic Variation: The Roma Paradigm Neus Font-Porterias,1 Rocio Caro-Consuegra,1 Marcel Lucas-Sanchez,1 Marie Lopez,2 Aaron Gimenez,3 Annabel Carballo-Mesa,4 Elena Bosch,1,5 Francesc Calafell ,1 Lluıs Quintana-Murci,2,6 and David Comas *,1 Downloaded from https://academic.oup.com/mbe/article/38/7/2804/6169539 by Consejo Superior de Investigaciones Cientificas (CSIC) user on 31 August 2021 1Departament de Cie`ncies Experimentals i de la Salut, Institut de Biologia Evolutiva (UPF-CSIC), Universitat Pompeu Fabra, Barcelona, Spain 2Human Evolutionary Genetics Unit, Institut Pasteur, UMR2000, CNRS, Paris, France 3Facultat de Sociologia, Universitat Autonoma de Barcelona, Barcelona, Spain 4Facultat de Geografia i Historia, Universitat de Barcelona, Barcelona, Spain 5Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Reus, Spain 6Human Genomics and Evolution, Colle`gedeFrance,Paris,France *Corresponding author: E-mail: [email protected]. Associate editor: Kelley Harris Abstract Demographic history plays a major role in shaping the distribution of genomic variation. Yet the interaction between different demographic forces and their effects in the genomesisnotfullyresolvedinhumanpopulations. Here, we focus on the Roma population, the largest transnational ethnic minority in Europe. They have a South Asian origin and their demographic history is characterized by recent dispersals, multiple founder events, and extensive gene flow from non- Roma groups. Through the analyses of new high-coverage whole exome sequences and genome-wide array data for 89 Iberian Roma individuals together with forward simulations, we show that founder effects have reduced their genetic diversity and proportion of rare variants, gene flow has counteracted the increase in mutational load, runs of homo- zygosity show ancestry-specific patterns of accumulation of deleterious homozygotes, and selection signals primarily derive from preadmixture adaptation in the Roma population sources.
[Show full text]
Whole Exome Sequencing in Families at High Risk for Hodgkin Lymphoma: Identification of a Predisposing Mutation in the KDR Gene
Hodgkin Lymphoma SUPPLEMENTARY APPENDIX Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene Melissa Rotunno, 1 Mary L. McMaster, 1 Joseph Boland, 2 Sara Bass, 2 Xijun Zhang, 2 Laurie Burdett, 2 Belynda Hicks, 2 Sarangan Ravichandran, 3 Brian T. Luke, 3 Meredith Yeager, 2 Laura Fontaine, 4 Paula L. Hyland, 1 Alisa M. Goldstein, 1 NCI DCEG Cancer Sequencing Working Group, NCI DCEG Cancer Genomics Research Laboratory, Stephen J. Chanock, 5 Neil E. Caporaso, 1 Margaret A. Tucker, 6 and Lynn R. Goldin 1 1Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 2Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 3Ad - vanced Biomedical Computing Center, Leidos Biomedical Research Inc.; Frederick National Laboratory for Cancer Research, Frederick, MD; 4Westat, Inc., Rockville MD; 5Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; and 6Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA ©2016 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol.2015.135475 Received: August 19, 2015. Accepted: January 7, 2016. Pre-published: June 13, 2016. Correspondence: [email protected] Supplemental Author Information: NCI DCEG Cancer Sequencing Working Group: Mark H. Greene, Allan Hildesheim, Nan Hu, Maria Theresa Landi, Jennifer Loud, Phuong Mai, Lisa Mirabello, Lindsay Morton, Dilys Parry, Anand Pathak, Douglas R. Stewart, Philip R. Taylor, Geoffrey S. Tobias, Xiaohong R. Yang, Guoqin Yu NCI DCEG Cancer Genomics Research Laboratory: Salma Chowdhury, Michael Cullen, Casey Dagnall, Herbert Higson, Amy A.
[Show full text]
Integrative Epigenomic and Genomic Analysis of Malignant Pheochromocytoma
EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 42, No. 7, 484-502, July 2010 Integrative epigenomic and genomic analysis of malignant pheochromocytoma Johanna Sandgren1,2* Robin Andersson3*, pression examination in a malignant pheochromocy- Alvaro Rada-Iglesias3, Stefan Enroth3, toma sample. The integrated analysis of the tumor ex- Goran̈ Akerstro̊ m̈ 1, Jan P. Dumanski2, pression levels, in relation to normal adrenal medulla, Jan Komorowski3,4, Gunnar Westin1 and indicated that either histone modifications or chromo- somal alterations, or both, have great impact on the ex- Claes Wadelius2,5 pression of a substantial fraction of the genes in the in- vestigated sample. Candidate tumor suppressor 1Department of Surgical Sciences genes identified with decreased expression, a Uppsala University, Uppsala University Hospital H3K27me3 mark and/or in regions of deletion were for SE-75185 Uppsala, Sweden 2 instance TGIF1, DSC3, TNFRSF10B, RASSF2, HOXA9, Department of Genetics and Pathology Rudbeck Laboratory, Uppsala University PTPRE and CDH11. More genes were found with in- SE-75185 Uppsala, Sweden creased expression, a H3K4me3 mark, and/or in re- 3The Linnaeus Centre for Bioinformatics gions of gain. Potential oncogenes detected among Uppsala University those were GNAS, INSM1, DOK5, ETV1, RET, NTRK1, SE-751 24 Uppsala, Sweden IGF2, and the H3K27 trimethylase gene EZH2. Our ap- 4Interdisciplinary Centre for Mathematical and proach to associate histone methylations and DNA Computational Modelling copy number changes to gene expression revealed ap- Warsaw University parent impact on global gene transcription, and en- PL-02-106 Warszawa, Poland abled the identification of candidate tumor genes for 5Corresponding author: Tel, 46-18-471-40-76; further exploration.
[Show full text]
Open Data for Differential Network Analysis in Glioma
International Journal of Molecular Sciences Article Open Data for Differential Network Analysis in Glioma , Claire Jean-Quartier * y , Fleur Jeanquartier y and Andreas Holzinger Holzinger Group HCI-KDD, Institute for Medical Informatics, Statistics and Documentation, Medical University Graz, Auenbruggerplatz 2/V, 8036 Graz, Austria; [email protected] (F.J.); [email protected] (A.H.) * Correspondence: [email protected] These authors contributed equally to this work. y Received: 27 October 2019; Accepted: 3 January 2020; Published: 15 January 2020 Abstract: The complexity of cancer diseases demands bioinformatic techniques and translational research based on big data and personalized medicine. Open data enables researchers to accelerate cancer studies, save resources and foster collaboration. Several tools and programming approaches are available for analyzing data, including annotation, clustering, comparison and extrapolation, merging, enrichment, functional association and statistics. We exploit openly available data via cancer gene expression analysis, we apply refinement as well as enrichment analysis via gene ontology and conclude with graph-based visualization of involved protein interaction networks as a basis for signaling. The different databases allowed for the construction of huge networks or specified ones consisting of high-confidence interactions only. Several genes associated to glioma were isolated via a network analysis from top hub nodes as well as from an outlier analysis. The latter approach highlights a mitogen-activated protein kinase next to a member of histondeacetylases and a protein phosphatase as genes uncommonly associated with glioma. Cluster analysis from top hub nodes lists several identified glioma-associated gene products to function within protein complexes, including epidermal growth factors as well as cell cycle proteins or RAS proto-oncogenes.
[Show full text]
Systematic Survey of the Role of IGF in the Link Between Diabetes and Cancer
HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Indiana Manuscript Author Univ J Undergrad Manuscript Author Res. Author manuscript; available in PMC 2019 March 20. Published in final edited form as: Indiana Univ J Undergrad Res. 2018 ; 4(1): 17–26. doi:10.14434/iujur.v4i1.24499. Systematic Survey of the Role of IGF in the Link Between Diabetes and Cancer Nirupama Devanathan and Dr. Ann C. Kimble-Hill [Faculty Mentor] Indiana University School of Medicine Abstract Epidemiological studies have proposed a link between type II diabetes and cancer via the IGF/ insulin signaling pathway, which includes insulin-like peptides (IGF1, IGF2, and insulin), insulin receptors (IR-A, IR-B, IGF1R, and hybrids), and insulin substrate proteins (IRS1–6). In this study, up- and down-regulation of various components in the IGF/insulin signaling pathway are compared to clinical outcomes for cancer patients; the components include diagnosis age, overall survival, tumor invasion and vascularization, and body mass index. It was found that the up- regulation of insulin growth Factor (IGF)/insulin components was associated with overall survival and tumor invasion and vascularization, while the down-regulation of equivalent components was not associated with clinical outcomes assessed in this study. Particularly, the up-regulation of DOK5, IGF2, and IRS2 in colorectal cancer and IGF1R in liver cancer is associated with significantly decreased overall survival. Functional aberrations in either of the two proteins in co- expression pairs were identified for each cancer and correlated with overall survival and diagnosis age. Specific biomarkers proposed in this study will be further analyzed to fine-tune consistent associations that can be translated to reliable prognostic standards for the roles of IGF/insulin signaling pathway modulations that promote cancer.
[Show full text]
The RET Receptor Is Linked to Stress Response Pathways
[CANCER RESEARCH 64, 4453–4463, July 1, 2004] The RET Receptor Is Linked to Stress Response Pathways Shirley M. Myers and Lois M. Mulligan Division of Cancer Biology and Genetics, Queen’s Cancer Research Institute, Queen’s University, Kingston, Ontario, Canada ABSTRACT viewed in Ref. 13). Furthermore, rearrangements of RET, resulting in juxtaposition of the RET kinase domain with a dimerization domain RET is a transmembrane receptor required for the development of from any of several other proteins, occur somatically in papillary neuroendocrine and urogenital cell types. Activation of RET has roles in cell growth, migration, or differentiation, yet little is known about the gene thyroid carcinoma (14). In each case, these mutations result in acti- expression patterns through which these processes are mediated. We have vation of the RET receptor, leading to inappropriate and/or increased generated cell lines stably expressing either the RET9 or RET51 protein RET-mediated signal transduction and resultant cell proliferation and isoforms and have used these to investigate RET-mediated gene expres- tumorigenesis. sion patterns by cDNA microarray analyses. As seen for many oncogenes, Activation of RET, either by ligand or through specific mutations, we identified altered expression of genes associated generally with cell– results in phosphorylation of multiple tyrosine residues that, in turn, cell or cell-substrate interactions and up-regulation of tumor-specific interact with specific adaptor molecules to trigger downstream sig- transcripts. We also saw increased expression of transcripts normally naling. Four of the tyrosines phosphorylated on RET activation, associated with neural crest or other RET-expressing cell types, suggesting these genes may lie downstream of RET activation in development.
[Show full text]
Behavioural Brain Research 276 (2015) 8–16
Behavioural Brain Research 276 (2015) 8–16 Contents lists available at ScienceDirect Behavioural Brain Research jou rnal homepage: www.elsevier.com/locate/bbr Research report A candidate syntenic genetic locus is associated with voluntary exercise levels in mice and humans a a b a, E. Kostrzewa , M.K. Brandys , H.A. van Lith , M.J.H. Kas ∗ a Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Centre Utrecht, Utrecht, Netherlands b Division of Animal Welfare & Laboratory Animal Science, Department of Animals in Science and Society, Faculty of Veterinary Medicine, Utrecht University & Brain Center Rudolf Magnus, University Medical Centre Utrecht, Utrecht, Netherlands h i g h l i g h t s Identiﬁcation of mouse QTL (Chr2) for voluntary running wheel activity (RWA). • RWA is considered a model of voluntary exercise (VE) in humans. • Human region 20q13.2 is syntenic to mouse QTL on Chr2. • Genetic variants within 20q13.2 are associated with VE. • This was demonstrated in two independent human cohorts. • a r t i c l e i n f o a b s t r a c t Article history: Individual levels of physical activity, and especially of voluntary physical exercise, highly contribute to Received 21 February 2014 the susceptibility for developing metabolic, cardiovascular diseases, and potentially to psychiatric dis- Received in revised form 1 May 2014 orders. Here, we applied a cross-species approach to explore a candidate genetic region for voluntary Accepted 2 May 2014 exercise levels. First, a panel of mouse chromosome substitution strains was used to map a genomic Available online 10 May 2014 region on mouse chromosome 2 that contributes to voluntary wheel running levels – a behavioral read- out considered a model of voluntary exercise in humans.
[Show full text]
Table S1. 103 Ferroptosis-Related Genes Retrieved from the Genecards
Table S1. 103 ferroptosis-related genes retrieved from the GeneCards. Gene Symbol Description Category GPX4 Glutathione Peroxidase 4 Protein Coding AIFM2 Apoptosis Inducing Factor Mitochondria Associated 2 Protein Coding TP53 Tumor Protein P53 Protein Coding ACSL4 Acyl-CoA Synthetase Long Chain Family Member 4 Protein Coding SLC7A11 Solute Carrier Family 7 Member 11 Protein Coding VDAC2 Voltage Dependent Anion Channel 2 Protein Coding VDAC3 Voltage Dependent Anion Channel 3 Protein Coding ATG5 Autophagy Related 5 Protein Coding ATG7 Autophagy Related 7 Protein Coding NCOA4 Nuclear Receptor Coactivator 4 Protein Coding HMOX1 Heme Oxygenase 1 Protein Coding SLC3A2 Solute Carrier Family 3 Member 2 Protein Coding ALOX15 Arachidonate 15-Lipoxygenase Protein Coding BECN1 Beclin 1 Protein Coding PRKAA1 Protein Kinase AMP-Activated Catalytic Subunit Alpha 1 Protein Coding SAT1 Spermidine/Spermine N1-Acetyltransferase 1 Protein Coding NF2 Neurofibromin 2 Protein Coding YAP1 Yes1 Associated Transcriptional Regulator Protein Coding FTH1 Ferritin Heavy Chain 1 Protein Coding TF Transferrin Protein Coding TFRC Transferrin Receptor Protein Coding FTL Ferritin Light Chain Protein Coding CYBB Cytochrome B-245 Beta Chain Protein Coding GSS Glutathione Synthetase Protein Coding CP Ceruloplasmin Protein Coding PRNP Prion Protein Protein Coding SLC11A2 Solute Carrier Family 11 Member 2 Protein Coding SLC40A1 Solute Carrier Family 40 Member 1 Protein Coding STEAP3 STEAP3 Metalloreductase Protein Coding ACSL1 Acyl-CoA Synthetase Long Chain Family Member 1 Protein
[Show full text]
Signatures of Adaptive Evolution in Platyrrhine Primate Genomes 5 6 Hazel Byrne*, Timothy H
1 2 Supplementary Materials for 3 4 Signatures of adaptive evolution in platyrrhine primate genomes 5 6 Hazel Byrne*, Timothy H. Webster, Sarah F. Brosnan, Patrícia Izar, Jessica W. Lynch 7 *Corresponding author. Email [email protected] 8 9 10 This PDF file includes: 11 Section 1: Extended methods & results: Robust capuchin reference genome 12 Section 2: Extended methods & results: Signatures of selection in platyrrhine genomes 13 Section 3: Extended results: Robust capuchins (Sapajus; H1) positive selection results 14 Section 4: Extended results: Gracile capuchins (Cebus; H2) positive selection results 15 Section 5: Extended results: Ancestral Cebinae (H3) positive selection results 16 Section 6: Extended results: Across-capuchins (H3a) positive selection results 17 Section 7: Extended results: Ancestral Cebidae (H4) positive selection results 18 Section 8: Extended results: Squirrel monkeys (Saimiri; H5) positive selection results 19 Figs. S1 to S3 20 Tables S1–S3, S5–S7, S10, and S23 21 References (94 to 172) 22 23 Other Supplementary Materials for this manuscript include the following: 24 Tables S4, S8, S9, S11–S22, and S24–S44 1 25 1) Extended methods & results: Robust capuchin reference genome 26 1.1 Genome assembly: versions and accessions 27 The version of the genome assembly used in this study, Sape_Mango_1.0, was uploaded to a 28 Zenodo repository (see data availability). An assembly (Sape_Mango_1.1) with minor 29 modifications including the removal of two short scaffolds and the addition of the mitochondrial 30 genome assembly was uploaded to NCBI under the accession JAGHVQ. The BioProject and 31 BioSample NCBI accessions for this project and sample (Mango) are PRJNA717806 and 32 SAMN18511585.
[Show full text]
Molecular Network of Collagen, Type III, Alpha-1 at the Gene Expression Level: Obstacles That Translational Research Must Overcome
Int. J. Mol. Sci. 2015, 16, 15031-15056; doi:10.3390/ijms160715031 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Article Differences between Mice and Humans in Regulation and the Molecular Network of Collagen, Type III, Alpha-1 at the Gene Expression Level: Obstacles that Translational Research Must Overcome Lishi Wang 1,2, Hongchao Liu 3, Yan Jiao 1,4, Erjian Wang 3, Stephen H. Clark 5, Arnold E. Postlethwaite 6,7, Weikuan Gu 1,7,* and Hong Chen 3,* 1 Department of Orthopedic Surgery and BME-Campbell Clinic, University of Tennessee Health Science Center, Memphis, TN 38163, USA; E-Mails: [email protected] (L.W.); [email protected] (Y.J.) 2 Department of Basic Research, Inner Mongolia Medical College, Inner Mongolia 010110, China 3 Integrative Research Center, the first Hospital of Qiqihaer City, Qiqihaer 161005, China; E-Mails: [email protected] (H.L.); [email protected] (E.W.) 4 Department of Medicine, Mudanjiang Medical College, Mudanjiang 157001, China 5 Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, CT 06030, USA; E-Mail: [email protected] 6 Department of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA; E-Mail: [email protected] 7 Research Service, Veterans Affairs Medical Center, Memphis, TN 38104, USA * Authors to whom correspondence should be addressed; E-Mails: [email protected] (W.G.); [email protected] (H.C.); Tel.: +01-901-448-2258 (W.G.); +86-452-242-5981 (H.C.); Fax: +01-901-448-6062 (W.G.); +86-452-247-0942 (H.C.).
[Show full text]
Rewiring Ret: PTB-Adaptor Regulated Signaling and Cell Biology
From the Department of Medical Biochemistry & Biophysics Karolinska Institutet, Stockholm, Sweden Rewiring Ret: PTB-adaptor regulated signaling and cell biology T. Kalle Lundgren Stockholm 2008 Published and printed by Karolinska University Press Box 200, SE-171 77 Stockholm, Sweden © T. Kalle Lundgren, 2008 ISBN 978-91-7409-032-1 Abstract The Ret receptor belongs to a group of transmembrane tyrosine kinase receptors that serve to transduce environmental signals into cellular responses. Upon extracellular ligand activation the receptors dimerize and their structural conformation is altered into one that allows for interaction with proteins in the cell cytosol. Among the most proximal interactors are PTB- adaptor molecules that dock to Ret tyrosine residues. As several PTB-adaptors compete for interaction with the same receptor-sequence the molecule that successfully binds to Ret excludes binding of any other PTB-adaptor at that time. Hence, the resulting signals are dependent on which adaptor that successfully engaged the receptor. In this work, Ret has been rewired to preferentially bind one PTB-adaptor on the expense of others to tyrosine 1062. This makes it possible to experimentally assign biochemical events as well as cell biological outcomes to one specific adaptor and so increasingly reveal how one common receptor may serve a plethora of functions depending on the subcellular milieu in which it operates. In paper I the important residues for Ret interaction with the Shc and Frs2α adaptors were investigated. Based on data from the effect on adaptor affinity for Ret by specifically substituting amino acids around tyrosine 1062, mutants could be established with selective recruitment of either Shc or Frs2α to this tyrosine.
[Show full text]